Speaker

A.J. Tibbetts

INTELLECTUAL PROPERTY ATTORNEY, SHAREHOLDER, GREENBERG TRAURIG, LLP
A.J. Tibbetts leverages his practical experience as a software developer to build IP strategies for computer-related inventions that are tailored to each client’s unique product and business strategy. A.J. guides biopharma companies on best practices in this field, including aligning IP for these innovations to a company’s overall IP strategy. His work covers computer-guided drug discovery, genome/epigenome analysis, bioreactor control, cell monitoring and differentiation, AI/ML, and more, for multinationals, research institutions, and startups. He serves on the board of directors of MassMEDIC and guides digital health efforts for MassBio.

A.J.’s holistic approach to software IP incorporates open source practices and trade secret policies alongside patents, and extends beyond protecting rights into licensing/ transactions, enforcement, and navigating diligence, as well as defending against infringement accusations. He has both invalidated software patents asserted against clients and defended software patents he wrote and prosecuted from being invalidated by competitors. A.J. closely studies the development of the law for protection of software inventions, enabling him to protect client’s interests despite the rapid evolution of both the law and the technology, and has helped draft amicus briefs on the Section 101 eligibility of software that were favorably cited by the Supreme Court and Court of Appeals for the Federal Circuit.

A.J. has served as an IP attorney in private practice for over 16 years, and prior to that served as a software developer, including for IBM. He received his J.D. from Suffolk University Law School and his B.S. in Computer Science and Computer & Systems Engineering from Rensselaer Polytechnic Institute.
Speaking In
3:00 PM - 4:00 PM
Tuesday, June 6
As computational analysis and informatics play an increasingly important role in R&D, biopharma…